The level of serum angiotensin-converting enzyme (ACE), which is responsible for cleaves of two amino acids from Ang I to form angiotensin II, is significantly higher in epithelial ovarian cancer (EOC) patients than in a control group. Here, AGT is linked to ovarian carcinoma.